Pneumococcal vaccination in adults: a review of the current recommendations
نویسندگان
چکیده
Abstract Pneumococcal disease remains a significant cause of morbidity and mortality, particularly in older adults individuals with underlying medical conditions. To address this public health threat, pneumococcal vaccines have been developed recommended for use adult populations. This article provides comprehensive review the current recommendations vaccination discusses burden population, including risk factors developing disease. The concludes discussion about future directions adults, new improved vaccines, which are to ensure wide protection against
منابع مشابه
Current Recommendations for Pneumococcal Vaccination of Children and Adults
Hossein Fakhraei , Soheila Khalilzadeh 2 , Ghamartaj Khanbabaei , Susan Mahmoudi, Mohammad Reza Masjedi , Mahshid Mehdizadeh , Abbas Momenzadeh, Alireza Nateghian , Payam Tabarsi , Parviz Tabatabaei , Davoud Yadegarinia 9 1 National Immunization Committee of Ministry of health, Tehran, Iran, 2 Clinical TB and Epidemiology Research Center, Masih Daneshvari Hospital, NRITLD, Shahid Beheshti Unive...
متن کاملPneumococcal vaccination in adults: recommendations, trends, and prospects.
The US Centers for Disease Control and Prevention recommends vaccination against Streptococcus pneumoniae for all people age 65 and older and also for younger people at high risk. However, experts continue to debate the efficacy of the vaccine; most observational studies found it beneficial, while clinical trials were inconclusive as a group. Although pneumococcal vaccination may or may not pro...
متن کاملNavigating pneumococcal vaccination in adults.
With two nonequivalent vaccines available and different recommendations for different patient populations, vaccination against Streptococcus pneumoniae can be confusing. Here we try to clarify the situation.
متن کاملPneumococcal vaccination of older adults
Pneumococcal polysaccharide vaccines have demonstrated effectiveness in prevention of invasive pneumococcal disease (IPD). 1 However, their effectiveness against non-invasive pneu-mococcal pneumonia or all-cause community-acquired pneumonia (CAP) has not been established; two recently published meta-analyses concluded that prevention of pneumococcal pneumonia could not be demonstrated for pneum...
متن کاملPneumococcal vaccination and revaccination of older adults.
As individuals advance in age, the risk of infection, bacteremia, and mortality caused by Streptococcus pneumoniae rises. Retrospective data demonstrate that the licensed penumococcal polysaccharide vaccine (PPV) is effective in older persons in reducing serotype-specific invasive disease. PPV demonstrates good immunogenicity in older adults, generally comparable to that in younger subjects, al...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pneumologia (Bucharest, Romania)
سال: 2022
ISSN: ['2067-2993', '2247-059X']
DOI: https://doi.org/10.2478/pneum-2023-0010